Friday, October 19, 2012
Durham Drug Developer BioCryst Pharmaceuticals Set to Buy Presidio Pharmaceuticals
Durham-based drug developer BioCryst Pharmaceuticals is buying San Francisco-based Presidio Pharmaceuticals in an attempt to develop new treatments for hepatitis C.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment